Antibodies to human goose-type lysozyme
US6660485B2 · kind B2 · utility
1Cited by
3References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 26, 2001 |
| Grant date | Dec 9, 2003 |
| Priority date | — |
| Expiry date | Jul 15, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N9/2462
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention provides a human goose-type lysozyme (GOLY) and polynucleotides which identify and encode GOLY. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating or preventing disorders associated with expression of GOLY.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.